Lucid Diagnostics Inc. Operating Income
Lucid Diagnostics Inc. (LUCD) reported Operating Income of -$12.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-12
- Lucid Diagnostics Inc. operating income (loss) for the quarter ending 2026-06-30 was -$12.80M.
- Lucid Diagnostics Inc. operating income (loss) for the quarter ending 2026-03-31 was -$12.11M.
- Lucid Diagnostics Inc. operating income (loss) for the quarter ending 2025-12-31 was -$14.01M.
- Lucid Diagnostics Inc. operating income (loss) for the quarter ending 2025-09-30 was -$11.76M.
- Lucid Diagnostics Inc. operating income (loss) for fiscal 2025 was -$49.64M.
- Lucid Diagnostics Inc. operating income (loss) for fiscal 2024 was -$46.05M.
- Lucid Diagnostics Inc. operating income (loss) for fiscal 2023 was -$48.48M.
- Lucid Diagnostics Inc. operating income (loss) for fiscal 2022 was -$56.25M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$12.80M 10-Q · filed 2026-08-12 | -$24.91M 10-Q · filed 2026-08-12 | -$38.93M derived: sum of 3 quarters · filed 2026-08-12 | -$50.69M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | -$12.11M 10-Q · filed 2026-05-13 | -$26.13M derived: sum of 2 quarters · filed 2026-05-13 | -$37.88M derived: sum of 3 quarters · filed 2026-05-13 | -$49.27M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -$14.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$25.77M derived: sum of 2 quarters · filed 2026-03-25 | -$37.15M derived: sum of 3 quarters · filed 2026-08-12 | -$49.64M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$11.76M 10-Q · filed 2025-11-12 | -$23.14M derived: sum of 2 quarters · filed 2026-08-12 | -$35.63M 10-Q · filed 2025-11-12 | -$48.01M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | -$11.38M 10-Q · filed 2026-08-12 | -$23.87M 10-Q · filed 2026-08-12 | -$36.25M derived: sum of 3 quarters · filed 2026-08-12 | -$47.94M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | -$12.49M 10-Q · filed 2026-05-13 | -$24.86M derived: sum of 2 quarters · filed 2026-05-13 | -$36.56M derived: sum of 3 quarters · filed 2026-05-13 | -$47.75M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$12.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$24.07M derived: sum of 2 quarters · filed 2026-03-25 | -$35.26M derived: sum of 3 quarters · filed 2026-03-25 | -$46.05M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | -$11.69M 10-Q · filed 2025-11-12 | -$22.89M derived: sum of 2 quarters · filed 2025-11-12 | -$33.68M 10-Q · filed 2025-11-12 | -$45.13M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$11.19M 10-Q · filed 2025-08-12 | -$21.98M 10-Q · filed 2025-08-12 | -$33.44M derived: sum of 3 quarters · filed 2025-08-12 | -$44.56M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$10.79M 10-Q · filed 2025-05-13 | -$22.25M derived: sum of 2 quarters · filed 2025-05-13 | -$33.37M derived: sum of 3 quarters · filed 2025-05-13 | -$44.96M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$11.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$22.58M derived: sum of 2 quarters · filed 2025-03-24 | -$34.16M derived: sum of 3 quarters · filed 2025-03-24 | -$48.48M 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | -$11.13M 10-Q · filed 2024-11-12 | -$22.71M derived: sum of 2 quarters · filed 2024-11-12 | -$37.03M 10-Q · filed 2024-11-12 | -$52.00M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$11.58M 10-Q · filed 2024-08-12 | -$25.90M 10-Q · filed 2024-08-12 | -$40.88M derived: sum of 3 quarters · filed 2024-08-12 | -$55.25M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | -$14.32M 10-Q · filed 2024-05-13 | -$29.29M derived: sum of 2 quarters · filed 2024-05-13 | -$43.67M derived: sum of 3 quarters · filed 2024-05-13 | -$58.30M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | -$14.97M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$29.35M derived: sum of 2 quarters · filed 2024-03-25 | -$43.98M derived: sum of 3 quarters · filed 2024-03-25 | -$56.25M 10-K · filed 2024-03-25 | -$56.17M 10-K · filed 2023-03-14 | |||
| 2022-09-30 | -$14.38M 10-Q · filed 2023-11-13 | -$14.35M 10-Q · filed 2022-11-14 | -$29.00M derived: sum of 2 quarters · filed 2023-11-13 | -$41.28M 10-Q · filed 2023-11-13 | -$41.24M 10-Q · filed 2022-11-14 | -$52.52M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$14.63M 10-Q · filed 2023-08-14 | -$14.62M 10-Q · filed 2022-08-15 | -$26.90M 10-Q · filed 2023-08-14 | -$26.89M 10-Q · filed 2022-08-15 | -$38.14M derived: sum of 3 quarters · filed 2023-08-14 | -$44.65M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$12.27M 10-Q · filed 2023-05-15 | -$12.10M 10-Q · filed 2022-05-16 | -$23.51M derived: sum of 2 quarters · filed 2023-05-15 | -$30.02M derived: sum of 3 quarters · filed 2023-05-15 | -$36.04M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -$11.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$17.75M derived: sum of 2 quarters · filed 2023-03-14 | -$23.77M derived: sum of 3 quarters · filed 2023-03-14 | -$27.42M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | -$6.51M 10-Q · filed 2022-11-14 | -$6.51M 10-Q · filed 2021-11-23 | -$12.53M derived: sum of 2 quarters · filed 2022-11-14 | -$16.18M 10-Q · filed 2022-11-14 | -$16.18M 10-Q · filed 2021-11-23 | -$18.91M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$6.02M 10-Q · filed 2022-08-15 | -$9.67M 10-Q · filed 2022-08-15 | -$12.40M derived: sum of 3 quarters · filed 2022-08-15 | -$14.42M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$3.65M 10-Q · filed 2022-05-16 | -$6.38M derived: sum of 2 quarters · filed 2022-05-16 | -$8.41M derived: sum of 3 quarters · filed 2022-05-16 | |||||
| 2020-12-31 | -$2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | -$4.75M derived: sum of 2 quarters · filed 2022-04-06 | -$8.28M 10-K · filed 2022-04-06 | |||||
| 2020-09-30 | -$2.02M 10-Q · filed 2021-11-23 | -$5.55M 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |